Emily M. Leproust
Chief Executive Officer at Twist Bioscience Corporation
Sits on 2 boards. Last updated September 27, 2026
Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 2 boards, counting each seat separately. Longest: Twist Bioscience Corporation, 3 years.
Twist Bioscience Corporation
Director · Chief Executive Officer
GeneDx Holdings Corp.
Director
Chief executive roles
Twist Bioscience Corporation
· Chief Executive Officer
Dates unknown
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 24, 2026 | Twist Bioscience Corporation | Open-market sale | −2,485 | $175.23 | $435,450 |
| Sep 24, 2026 | Twist Bioscience Corporation | Open-market sale | −945 | $176.39 | $166,690 |
| Sep 24, 2026 | Twist Bioscience Corporation | Open-market sale | −164 | $177.17 | $29,056 |
| Sep 24, 2026 | Twist Bioscience Corporation | Open-market sale | −330 | $178.67 | $58,961 |
| Sep 24, 2026 | Twist Bioscience Corporation | Open-market sale | −143 | $179.93 | $25,730 |
| Sep 24, 2026 | Twist Bioscience Corporation | Open-market sale | −515 | $180.39 | $92,901 |
| Sep 24, 2026 | Twist Bioscience Corporation | Open-market sale | −21 | $181.45 | $3,810 |
| Sep 24, 2026 | Twist Bioscience Corporation | Open-market sale | −16 | $182.50 | $2,920 |
| Sep 24, 2026 | Twist Bioscience Corporation | Open-market sale | −501 | $183.76 | $92,066 |
| Sep 24, 2026 | Twist Bioscience Corporation | Open-market sale | −83 | $184.60 | $15,322 |
| Sep 21, 2026 | Twist Bioscience Corporation | Open-market sale | −1,687 | $165.49 | $279,183 |
| Sep 17, 2026 | Twist Bioscience Corporation | Option exercise | +133,269 | $26.66 | $3,552,952 |
| Sep 17, 2026 | Twist Bioscience Corporation | Option exercise | +75,439 | $8.82 | $665,372 |
| Sep 17, 2026 | Twist Bioscience Corporation | Open-market sale | −2,440 | $151.46 | $369,566 |
| Sep 17, 2026 | Twist Bioscience Corporation | Open-market sale | −6,644 | $152.21 | $1,011,291 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.